Leap Therapeutics Announces $58.9 Million Private Placement Led by Winklevoss Capital to Launch Digital Asset Treasury Strategy
I'm PortAI, I can summarize articles.
Leap Therapeutics Inc. has announced a $58.88 million private placement led by Winklevoss Capital to support its new digital asset treasury strategy. The financing includes the sale of approximately 95.8 million shares of common stock and additional warrants for about 71.9 million shares at an exercise price of $0.5335 per share. The closing of the private placement is expected soon, pending customary conditions. Parcrest is the placement agent, with legal advice from Morgan, Lewis & Bockius LLP and Cooley LLP.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments